AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Stoke Therapeutics, Inc.

$26.29 -$4.61 (-14.92%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$26.35
Day Range
$25.91$26.71
Year Range
$20.32$40.22
Market Cap
1.7B
AVG Volume
997.7K
Trailing/Forward PE
-6.94/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2027-03-15
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0100M200M300M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
STOK Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q328.21M
26 Q227.59M
26 Q132.08M
25 Q4184.42M
25 Q3205.63M
25 Q2199.89M
25 Q1190.91M
24 Q436.55M
24 Q316.74M
24 Q215.16M
Net Income (USD) · TTM
-300M-200M-100M0100M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
STOK Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q3-243.2M
26 Q2-207.9M
26 Q1-169.77M
25 Q4-6.88M
25 Q340.57M
25 Q252.48M
25 Q150.27M
24 Q4-88.98M
24 Q3-105.46M
24 Q2-103.57M
Operating Income (USD) · TTM
-300M-200M-100M0100M24 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q3
STOK Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q3-257.6M
26 Q2-223.38M
26 Q1-185.25M
25 Q4-20.59M
25 Q327.2M
25 Q240.28M
25 Q138.24M
24 Q4-101.37M
24 Q3-117.3M
24 Q2-114.53M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: STOK

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 15 Mar 2027.

Stoke Therapeutics, Inc.
STOK
Stockpicker

Video analysis: STOK

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: STOK

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.